Search Login Register

Embryonal Rhabdomyosarcoma Summary

167 relevant articles (4 outcomes, 16 trials/studies) found for this Disease

Description: A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed, p2188)

Also Known As: Rhabdomyosarcoma, Embryonal; Embryonal Rhabdomyosarcomas; Rhabdomyosarcomas, Embryonal

Key Drugs and Agents for Embryonal Rhabdomyosarcoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cyclophosphamide (Cytoxan) : 1 outcome in 7 results : FDA 10
  2. Paraffin : 2 studies in 6 results : IBA
  3. Desmin : 1 study in 18 results : IBA
  4. Messenger RNA (mRNA) : 1 study in 7 results : IBA
  5. DNA (Deoxyribonucleic Acid) : 1 study in 7 results : IBA
  6. Vimentin : 1 study in 6 results : IBA
  7. Antibodies : 1 study in 6 results : IBA
  8. Myoglobin : 1 study in 4 results : IBA
  9. Formaldehyde (Formol) : 1 study in 4 results : IBA
  10. Phosphopyruvate Hydratase (Enolase) : 1 study in 2 results : IBA
Show All >>

Diseases Related to Embryonal Rhabdomyosarcoma

  1. Sarcoma (Soft Tissue Sarcoma)
  2. Rhabdomyosarcoma
  3. Neoplasms (Cancer)
  4. Alveolar Rhabdomyosarcoma
  5. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
Show All >>

Key Therapies for Embryonal Rhabdomyosarcoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2 outcomes 2 studies in 41 results
  2. Combination Drug Therapy (Combination Chemotherapy) : 1 outcome in 5 results
  3. Aftercare (After-Treatment) : 1 study in 3 results
  4. Adjuvant Chemotherapy : 4 results
  5. Hysterectomy : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.